Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
US Stocks

PATH (UiPath, NYSE) up 6.82% ahead of 11 Mar 2026 earnings: analyst targets to watch

March 12, 2026
4 min read
Share with:

We note PATH stock climbed 6.82% to $12.38 on heavy volume as UiPath (PATH) heads into Q4 earnings on 11 Mar 2026. This session closed with 111,433,101.00 shares traded, a relative volume of 3.11, signaling strong investor attention. We focus on how revenue growth, a PE of 29.43, and guidance will drive the short-term PATH stock move.

PATH stock: Q4 earnings setup and timing

UiPath (PATH) reports after market on 11 Mar 2026, creating a classic pre-earnings volatility setup for PATH stock. Institutional and insider activity matters: 62.50% of shares are held by institutions and insiders have sold blocks recently, which can amplify moves in PATH stock.

Sponsored

PATH earnings drivers and financials

Revenue per share TTM is 2.88 and EPS TTM is 0.42, metrics investors will watch in the PATH earnings release. Current market cap is 6608687787.00 USD and cash per share is 2.59, supporting liquidity arguments in PATH analysis.

PATH stock valuation and analyst targets

PATH stock trades at a trailing PE of 29.43 and a price-to-sales ratio near 4.21, leaving valuation concerns for some investors. Wall Street consensus trends to Hold with a reported consensus price target near 15.77 USD, which frames analyst expectations in PATH price target discussions. source

Meyka AI rates PATH with a score and forecast

Meyka AI rates PATH with a score out of 100: 76.49 (B+), Suggestion: BUY. This grade factors in S&P 500 and sector comparison, financial growth, key metrics and analyst consensus. Meyka AI’s forecast model projects a yearly price of 13.83 USD, which implies an upside of 11.75% from the current 12.38 USD; forecasts are model-based projections and not guarantees.

PATH stock technicals and trading signals

Momentum indicators show RSI 54.88 and MACD histogram 0.33, which suggests neutral-to-mild bullish momentum for PATH stock. Short-term technicals highlight Bollinger upper band at 12.33 USD and an ATR of 0.71 USD, indicating the next trading range for PATH stock may be volatile.

PATH analysis: risks, opportunities and sector context

Sector peers in Software – Infrastructure are mixed, so PATH stock will be sensitive to broader tech sentiment and RPA adoption news. Key risks include stretched valuation ratios and long receivable days (DSO 116.59), while opportunities include expanding automation adoption and improving free cash flow metrics in PATH analysis.

Final Thoughts

Key takeaways for PATH stock ahead of the Q4 report: we view the stock as liquid and news-sensitive after today’s 6.82% move and 111,433,101.00 shares traded. UiPath shows operating cash flow per share 0.62 and a healthy current ratio 2.54, but valuation at PE 29.43 requires revenue or margin beats to re-rate. Meyka AI’s forecast model projects 13.83 USD for the year, implying 11.75% upside versus the current 12.38 USD; forecasts are model-based projections and not guarantees. Use earnings guidance and management commentary to judge whether PATH stock can sustain a move toward analyst targets ~15.77 USD or higher. We include this analysis using Meyka AI as an AI-powered market analysis platform to frame the numbers investors need to watch.

FAQs

When does UiPath report and why does it matter for PATH stock?

UiPath reports Q4 on 11 Mar 2026 after the close; the release matters because guidance, revenue growth, and EPS of 0.42 will drive near-term PATH stock volatility.

What is Meyka AI’s PATH stock forecast and upside?

Meyka AI’s forecast model projects a yearly price of 13.83 USD, implying an upside of 11.75% from the current 12.38 USD; forecasts are model-based and not guarantees.

What valuation metrics should investors watch in PATH analysis?

Investors should watch trailing PE at 29.43, price-to-sales near 4.21, and free cash flow yield about 4.76% when doing PATH stock valuation checks before and after earnings.

Is PATH stock a buy after the pre-earnings move?

The Meyka grade is B+ (76.49) suggesting a BUY stance relative to peers, but investors should wait for earnings details and guidance before deciding on PATH stock exposure.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
Meyka Newsletter
Get analyst ratings, AI forecasts, and market updates in your inbox every morning.
12% average open rate and growing
Trusted by 4,200+ active investors
Free forever. No spam. Unsubscribe anytime.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask our AI about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)